FDA Inspection 868458 — Rebecca Kruse-Jarrees, MD

Rebecca Kruse-Jarrees, MD — FEI 3010677043

The FDA completed an inspection of Rebecca Kruse-Jarrees, MD on Feb 19, 2014 in New Orleans, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 19, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
New Orleans, LA (United States)

Additional Details

Clinical Investigator (CI)